Initial evaluation of the nonsmall cell lung cancer patient: Diagnosis and staging

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 4, 2010, Pages 307-314

  Almeida, Francisco A ^a   Uzbeck, Mateen ^a   Ost, David ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Endobronchial ultrasound; Lung cancer diagnosis; Lung cancer staging; PET

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER STAGING; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; ENDOBRONCHIAL ULTRASONOGRAPHY; HISTOPATHOLOGY; HUMAN; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MEDIASTINUM LYMPH NODE; METASTASIS; MUTATIONAL ANALYSIS; ONCOGENE K RAS; POSITRON EMISSION TOMOGRAPHY; REVIEW; TRANSBRONCHIAL ASPIRATION; TUMOR BIOPSY; ANAMNESIS; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC ULTRASONOGRAPHY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; PATHOLOGY; PHYSICAL EXAMINATION;

BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSIS, DIFFERENTIAL; ENDOSONOGRAPHY; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MEDICAL HISTORY TAKING; NEOPLASM STAGING; PHYSICAL EXAMINATION; POSITRON-EMISSION TOMOGRAPHY; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; BIOMARKERS, TUMOR;

EID: 77953651770     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32833ab0b6     Document Type: Review

References (45)

1. Buccheri G, Ferrigno D. Lung cancer: clinical presentation and specialist referral time. Eur Respir J 2004; 24:898-904.
2. Hamilton W, Peters TJ, Round A, Sharp D. What are the clinical features of lung cancer before the diagnosis is made? A population based case control study. Thorax 2005; 60:1059-1065.
3. Silvestri GA, Littenberg B, Colice GL. The clinical evaluation for detecting metastatic lung cancer. Am J Respir Crit Care Med 1995; 152:225-230.
4. Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive staging of nonsmall cell lung cancer. Chest 2007; 132:178S-201S.
5. Almeida F, Kane G. Approach to mediastinal masses. Hosp Physician Pulm Dis Board Rev Man 2007; 12:2-12.
6. Truong MT, Munden RF, Movsas B. Imaging to optimally stage lung cancer: conventional modalities and PET/CT. J Am Coll Radiol 2004; 1:957-964.
7. Rivera MP, Mehta AC. Initial diagnosis of lung cancer. Chest 2007; 132:131S-148S.
8. Gomez M, Silvestri GA. Endobronchial ultrasound for the diagnosis and staging of lung cancer. Proc Am Thorac Soc 2009; 6:180-186.
9. Maziak DE, Darling GE, Inculet RI, et al. Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med 2009; 151:221-228.
10. Fischer B, Lassen U, Mortensen J, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009; 361:32-39.
11. Ost D, Fein AM, Feinsilver SH. The solitary pulmonary nodule. N Engl J Med 2003; 348:2535-2542.
12. Naruke T, Goya T, Tsuchiya R, Suemasu K. The importance of surgery to nonsmall cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surgery 1988; 46:603-610.
13. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182:319-323.
14. Arita T, Kuramitsu T, Kawamura M, et al. Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes. Thorax 1995; 50:1267-1269.
15. Seely JM, Mayo JR, Miller RR, Müller NL. T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT. Radiology 1993; 186:129-132.
16. Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with nonsmall-cell lung cancer: a meta-analysis. Ann Intern Med 2003; 139:879-892.
17. De Wever W, Ceyssens S, Mortelmans L, et al. Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT. Eur Radiol 2007; 17:23-32. (Pubitemid 46063025)
18. Lardinois D, Weder W, Roudas M, et al. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol 2005; 23:6846-6853.
19. Hsia TC, Shen YY, Yen RF, et al. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with nonsmall cell lung cancer. Neoplasma 2002; 49:267-271.
20. Bury T, Barreto A, Daenen F, et al. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with nonsmall cell lung cancer. Eur J Nucl Med 1998; 25:1244-1247.
21. Schellinger PD,Meinck HM, Thron A. Diagnostic accuracy ofMRI compared to CCT in patients with brain metastases. J Neurooncol 1999; 44:275-281.
22. Davis PC, Hudgins PA, Peterman SB, Hoffman JC Jr. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast enhanced MR imaging. AJNR Am J Neuroradiol 1991; 12:293-300.
23. NCCN Practice guidelines in oncology. Non-small cell lung cancer v.2.2010. Available at: http://www.nccn.org/professionals/physician-gls/PDF/ nscl.pdf.
24. Gandara DR, Mack PC, Li T, et al. Evolving treatment algorithms for advanced nonsmall-cell lung cancer: 2009 looking toward 2012. Clin Lung Cancer 2009; 10:392-394.
25. Ciuleanu T, Brodowicz T, Zielinski C, et al. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for nonsmall-cell lung cancer: a randomised, double-blind, phase 3 study. Lancet 2009; 374:1432-1440.
26. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage nonsmall-cell lung cancer. J Clin Oncol 2008; 26:3543-3551.
27. Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009; 361:947-957.
28. Azzoli CG, Baker S Jr, Temin S, et al. American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV nonsmall-cell lung cancer. J Clin Oncol 2009; 27:6251-6266.
29. Kalikaki A, Koutsopoulos A, Trypaki M, et al. Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC. Br J Cancer 2008; 99:923-929.
30. Daniele L, Cassoni P, Bacillo E, et al. Epidermal growth factor receptor gene in primary tumor and metastatic sites from nonsmall cell lung cancer. J Thorac Oncol 2009; 4:684-688.
31. Park S, Holmes-Tisch AJ, Cho EY, et al. Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in nonsmall cell lung cancer. J Thorac Oncol 2009; 4:809-815.
32. Schmid K, Oehl N, Wrba F, et al. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases. Clin Cancer Res 2009; 15:4554-4560.
33. Detterbeck FC, Jantz MA, Wallace M, et al. Invasive mediastinal staging of lung cancer. Chest 2007; 132:202S-220S.
34. Medford AR, Bennett JA, Free CM, Agrawal S. Mediastinal staging procedures in lung cancer: EBUS, TBNA and mediastinoscopy. Curr Opin Pulm Med 2009; 15:334-342.
35. Ernst A, Anantham D, Eberhardt R, et al. Diagnosis of mediastinal adenopathyreal- time endobronchial ultrasound guided needle aspiration versus mediastinoscopy. J Thorac Oncol 2008; 3:577-582.
36. Tournoy KG, De Ryck F, Vanwalleghem LR, et al. Endoscopic ultrasound reduces surgical mediastinal staging in lung cancer: a randomized trial. Am J Respir Crit Care Med 2008; 177:531-553.
37. Wallace MB, Pascual JM, Raimondo M, et al. Minimally invasive endoscopic staging of suspected lung cancer. JAMA 2008; 299:540-546.
38. Rintoul RC, Tournoy KG, El Daly H, et al. EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes: an international multicentre experience. J Thorac Oncol 2009; 4:44-48.
39. Szlubowski A, Kuzdzal J, Kolodziej M, et al. Endobronchial ultrasound-guided needle aspiration in the nonsmall cell lung cancer staging. Eur J Cardiothorac Surg 2009; 35:332-335.
40. Cerfolio RJ, Bryant AS, Ojha B, Eloubeidi M. Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg 2005; 80:1207-1213.
41. Herth FJ, Eberhardt R, Mark Krasnik M, Ernst A. Endobronchial ultrasoundguided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest 2008; 133:887-891.
42. Gürses A, Turna A, Bedirhan MA, et al. The value of mediastinoscopy in preoperative evaluation of mediastinal involvement in nonsmall-cell lung cancer patients with clinical NO disease. Thorac Cardiovasc Surg 2002; 50:174-177.
43. Choi YS, Shim YM, Kim J, Kim K. Mediastinoscopy in patients with clinical stage I nonsmall cell lung cancer. Ann Thorac Surg 2003; 75:364-366.
44. Yuan S, Sun X, Li M, et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 2007; 30:239-244.
45. Belderbos JS, Kepka L, Spring Kong FM, et al. Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: nonsmall-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 2008; 72:335-342.